Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs Dexamethasone-Ondansetron for PONV Prevention
NCT03603119Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- May 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of midazolam in postoperative nausea and vomiting (PONV), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 24 hours. Started May 2018; status: completed.
02
Drugs
midazolam
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03603119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03603119.